105 related articles for article (PubMed ID: 1888181)
21. Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2.
Jordan A; Stein J
Eur J Nutr; 2003 Dec; 42(6):324-31. PubMed ID: 14673605
[TBL] [Abstract][Full Text] [Related]
22. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.
McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ
Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143
[TBL] [Abstract][Full Text] [Related]
23. 5-Fluorouracil induces apoptotic cell death with G2 phase arrest in human breast cancer grafted in nude mice.
Okamoto S; Sakai M; Uchida J; Saito H
Anticancer Res; 1996; 16(5A):2699-704. PubMed ID: 8917373
[TBL] [Abstract][Full Text] [Related]
24. Circadian variations in cell cycle phase distribution in a squamous cell carcinoma xenograft; effects of cisplatin and fluorouracil treatment.
Rydell R; Wennerberg J; Willen R
In Vivo; 1990; 4(6):385-9. PubMed ID: 2103378
[TBL] [Abstract][Full Text] [Related]
25. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
Ji YB; Zhou JH; Zuo MX; You QD
Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
[TBL] [Abstract][Full Text] [Related]
26. [Effects of cisplatin on cultured glioma cells].
Honda C; Tabuchi K
Gan To Kagaku Ryoho; 1986 May; 13(5):1921-6. PubMed ID: 3707152
[TBL] [Abstract][Full Text] [Related]
27. Effects of developmental stage and tissue type on embryo/fetal DNA distributions and 5-fluorouracil-induced cell-cycle perturbations.
Elstein KH; Zucker RM; Andrews JE; Ebron-McCoy M; Shuey DL; Rogers JM
Teratology; 1993 Oct; 48(4):355-63. PubMed ID: 8278935
[TBL] [Abstract][Full Text] [Related]
28. Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cells.
Ijichi K; Adachi M; Hasegawa Y; Ogawa T; Nakamura H; Kudoh A; Yasui Y; Murakami S; Ishizaki K
Cancer Chemother Pharmacol; 2008 Oct; 62(5):745-52. PubMed ID: 18075740
[TBL] [Abstract][Full Text] [Related]
29. [Studies on cell kinetics in leukemia using flow cytometry].
Yoshida K
Hokkaido Igaku Zasshi; 1982 Sep; 57(5):557-71. PubMed ID: 7152463
[TBL] [Abstract][Full Text] [Related]
30. The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo.
Grégoire V; Van NT; Stephens LC; Brock WA; Milas L; Plunkett W; Hittelman WN
Cancer Res; 1994 Dec; 54(23):6201-9. PubMed ID: 7954467
[TBL] [Abstract][Full Text] [Related]
31. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R; Tanabe K; Inoue H; Toge T
Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
[TBL] [Abstract][Full Text] [Related]
32. The effect of calmodulin antagonist berbaminederivative-EBB on hepatoma in vitro and in vivo.
Liu J; Qi S; Zhu H; Zhang J; Li Z; Wang T
Chin Med J (Engl); 2002 May; 115(5):759-62. PubMed ID: 12133551
[TBL] [Abstract][Full Text] [Related]
33. Radiation-induced cell cycle delay measured in two mouse tumors in vivo using bromodeoxyuridine.
Wilson GD; Martindale CA; Soranson JA; Bourhis J; Carl UM; McNally NJ
Radiat Res; 1994 Feb; 137(2):177-85. PubMed ID: 8134541
[TBL] [Abstract][Full Text] [Related]
34. [Establishment of a cisplatin-induced human hepatocellular carcinoma drug-resistant cell line and its biological characteristics].
Yang JX; Tang WX
Ai Zheng; 2002 Aug; 21(8):872-6. PubMed ID: 12478896
[TBL] [Abstract][Full Text] [Related]
35. Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.
Nio Y; Hirahara N; Minari Y; Iguchi C; Yamasawa K; Toga T; Tamura K
Anticancer Res; 2000; 20(5A):3293-9. PubMed ID: 11062756
[TBL] [Abstract][Full Text] [Related]
36. [Fundamental study of combination chemotherapy with THP, 5-FU and CDDP for human KB carcinoma cell line and its multidrug resistant cell line KB-C1--usefulness of treatment with 5-FU preceding CDDP].
Kishimoto H; Manno Y; Tanaka H; Moridera K; Urade M
Gan To Kagaku Ryoho; 2001 Apr; 28(4):505-9. PubMed ID: 11329785
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of 3,5,3'-triiodothyronine on control and mdx myoblasts and fibroblasts: analysis by flow cytometry.
Pernitsky AN; Anderson JE
Exp Cell Res; 1996 Sep; 227(2):214-22. PubMed ID: 8831559
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel-induced modification of the effects of radiation and alterations in the cell cycle in normal and tumor mammalian cells.
Gorodetsky R; Levdansky L; Ringel I; Vexler A
Radiat Res; 1998 Sep; 150(3):283-91. PubMed ID: 9728657
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometric evaluation of the cytotoxicity of novel antiviral compounds.
Nassiri MR; Hudson JL; Pudlo JS; Birch GM; Townsend LB; Drach JC
Cytometry; 1990; 11(3):411-7. PubMed ID: 2160365
[TBL] [Abstract][Full Text] [Related]
40. Biologically based dose-response modeling in developmental toxicology: biochemical and cellular sequelae of 5-fluorouracil exposure in the developing rat.
Shuey DL; Lau C; Logsdon TR; Zucker RM; Elstein KH; Narotsky MG; Setzer RW; Kavlock RJ; Rogers JM
Toxicol Appl Pharmacol; 1994 May; 126(1):129-44. PubMed ID: 8184423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
